IDEAS home Printed from https://ideas.repec.org/a/nat/nature/v616y2023i7955d10.1038_s41586-023-05838-7.html
   My bibliography  Save this article

RHOJ controls EMT-associated resistance to chemotherapy

Author

Listed:
  • Maud Debaugnies

    (Université Libre de Buxelles (ULB)
    Université Libre de Bruxelles (ULB))

  • Sara Rodríguez-Acebes

    (Spanish National Cancer Research Centre)

  • Jeremy Blondeau

    (Université Libre de Buxelles (ULB))

  • Marie-Astrid Parent

    (Université Libre de Buxelles (ULB))

  • Manuel Zocco

    (Université Libre de Buxelles (ULB))

  • Yura Song

    (Université Libre de Buxelles (ULB))

  • Viviane Maertelaer

    (Université Libre de Bruxelles (ULB)
    Université Libre de Bruxelles (ULB))

  • Virginie Moers

    (Université Libre de Buxelles (ULB))

  • Mathilde Latil

    (Université Libre de Buxelles (ULB))

  • Christine Dubois

    (Université Libre de Buxelles (ULB))

  • Katia Coulonval

    (Université Libre de Bruxelles (ULB)
    Université Libre de Bruxelles (ULB))

  • Francis Impens

    (Ghent University)

  • Delphi Haver

    (Ghent University)

  • Sara Dufour

    (Ghent University)

  • Akiyoshi Uemura

    (Nagoya City University Graduate School of Medical Sciences)

  • Panagiota A. Sotiropoulou

    (Université Libre de Buxelles (ULB))

  • Juan Méndez

    (Spanish National Cancer Research Centre)

  • Cédric Blanpain

    (Université Libre de Buxelles (ULB)
    Université Libre de Bruxelles (ULB))

Abstract

The resistance of cancer cells to therapy is responsible for the death of most patients with cancer1. Epithelial-to-mesenchymal transition (EMT) has been associated with resistance to therapy in different cancer cells2,3. However, the mechanisms by which EMT mediates resistance to therapy remain poorly understood. Here, using a mouse model of skin squamous cell carcinoma undergoing spontaneous EMT during tumorigenesis, we found that EMT tumour cells are highly resistant to a wide range of anti-cancer therapies both in vivo and in vitro. Using gain and loss of function studies in vitro and in vivo, we found that RHOJ—a small GTPase that is preferentially expressed in EMT cancer cells—controls resistance to therapy. Using genome-wide transcriptomic and proteomic profiling, we found that RHOJ regulates EMT-associated resistance to chemotherapy by enhancing the response to replicative stress and activating the DNA-damage response, enabling tumour cells to rapidly repair DNA lesions induced by chemotherapy. RHOJ interacts with proteins that regulate nuclear actin, and inhibition of actin polymerization sensitizes EMT tumour cells to chemotherapy-induced cell death in a RHOJ-dependent manner. Together, our study uncovers the role and the mechanisms through which RHOJ acts as a key regulator of EMT-associated resistance to chemotherapy.

Suggested Citation

  • Maud Debaugnies & Sara Rodríguez-Acebes & Jeremy Blondeau & Marie-Astrid Parent & Manuel Zocco & Yura Song & Viviane Maertelaer & Virginie Moers & Mathilde Latil & Christine Dubois & Katia Coulonval &, 2023. "RHOJ controls EMT-associated resistance to chemotherapy," Nature, Nature, vol. 616(7955), pages 168-175, April.
    • Handle: RePEc:nat:nature:v:616:y:2023:i:7955:d:10.1038_s41586-023-05838-7
    DOI: 10.1038/s41586-023-05838-7
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/s41586-023-05838-7
    File Function: Abstract
    Download Restriction: Access to the full text of the articles in this series is restricted.
    File URL: https://libkey.io/10.1038/s41586-023-05838-7?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Buer Sen & Zhihui Xie & Michelle D. Thomas & Samantha G. Pattenden & Sean Howard & Cody McGrath & Maya Styner & Gunes Uzer & Terrence S. Furey & Janet Rubin, 2024. "Nuclear actin structure regulates chromatin accessibility," Nature Communications, Nature, vol. 15(1), pages 1-15, December.
    2. Dongsheng Tang & Minhui Cui & Bin Wang & Ganghao Liang & Hanchen Zhang & Haihua Xiao, 2024. "Nanoparticles destabilizing the cell membranes triggered by NIR light for cancer imaging and photo-immunotherapy," Nature Communications, Nature, vol. 15(1), pages 1-21, December.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:nature:v:616:y:2023:i:7955:d:10.1038_s41586-023-05838-7. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.